Penn Valley, PA, United States of America

Mark I Greene

USPTO Granted Patents = 72 (Patent Applications = 18)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 10 (Patent Applications = 5)

Average Co-Inventor Count = 3.0

ph-index = 18

Forward Citations = 927(Granted Patents)

Forward Citations (Not Self Cited) = 813(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

71 out of 2,596

University of Pennsylvania

Colorado State University Research Foundation

patents

5. 1 out of 2,341

University of Illinois

patents

6. 1 out of 281

The Children's Hospital of Philadelphia

patents

7. 1 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2025

Loading Chart...

Areas of Expertise:

Anti-Platelet Factor 4 Antibodies

Heparin-Induced Thrombocytopenia

Cancer Radiation Therapy

Antigen-Binding Proteins

Tumor Necrosis Factor Inhibitors

Bifunctional Enzyme-Building Molecules

Mutation Mimicking Compounds

Prostate Cancer Detection

ErbB Interface Peptidomimetics

Autoimmune Colitis Therapy

Osteoclast Activity Inhibition

Immunodetection of Epitopes

72 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12304948 - Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia (2025-05-20),

2. 12282028 - Atomic description of immune complex that causes heparin-induced thrombocytopenia (2025-04-21),

3. 11913963 - Atomic description of immune complex that causes heparin-induced thrombocytopenia (2024-02-27),

4. 11524999 - Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia (2022-12-13),

5. 11446516 - Methods of increasing response to cancer radiation therapy (2022-09-20),

6. 11435362 - Atomic description of immune complex that causes heparin-induced thrombocytopenia (2022-09-06),

7. 11312784 - IgG binding peptides and multifunctional antigen-binding proteins comprising the same (2022-04-26),

8. 10583166 - Antigen-binding proteins comprising recombinant protein scaffolds (2020-03-10),

9. 10371705 - Atomic description of immune complex that causes heparin-induced thrombocytopenia (2019-08-06),

10. 9751830 - Inhibitors of the tumor necrosis factor receptor complex (2017-09-05),

11. 9701631 - TIP60 inhibitors (2017-07-11),

12. 9695252 - Antigen-binding proteins comprising recombinant protein scaffolds (2017-07-04),

13. 9321759 - Methods and use of bifunctional enzyme-building clamp-shaped molecules (2016-04-26),

14. 9295676 - Mutation mimicking compounds that bind to the kinase domain of EGFR (2016-03-29),

15. 9265739 - Methods and use of compounds that bind to HER2/neu receptor complex (2016-02-23),

Title: The Innovative Journey of Mark I Greene

Introduction: Mark I Greene, a visionary inventor based in Penn Valley, PA (US), has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Mark I Greene holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices.

Career Highlights: With a career spanning over two decades, Mark I Greene has been at the forefront of innovation, leading research and development teams to create cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Mark I Greene has collaborated with leading universities, research institutions, and tech companies to bring his inventions to life. His collaborative spirit has led to the successful implementation of groundbreaking technologies.

Conclusion: Mark I Greene's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire future generations of innovators to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.